Every round on record, with the sources behind each and the investors on them.
A clinical-stage speciality pharmaceutical company
nanomerics.comLinkedInLondon, UKBiotechFounded 2010
16 sources · checked 33 times, last 6d ago
Developing: it holds up against its sources so far, and firms up as more reporting lands.
ACCESS Newswire dates the release September 29, while Nanomerics’ own release is dated September 30; the company release wins.
| Round | Amount | Announced | Lead | Buzz |
|---|---|---|---|---|
| Series A | n/a | 2026-09-29 | not stated | No recent discussion |
16 sources · checked 33 times, last 6d ago [ DEVELOPING ] Developing: it holds up against its sources so far, and firms up as more reporting lands. read against 4 of 16 sources
ACCESS Newswire dates the release September 29, while Nanomerics’ own release is dated September 30; the company release wins. | ||||
Nanomerics builds precision medicines using proprietary molecular-engineered drug-delivery platforms for ophthalmology and central-nervous-system conditions.
Checked against 8 sources on Sep 30